UCI MEDICAL AFFILIATES INC
NT 10-Q, 2000-05-15
SPECIALTY OUTPATIENT FACILITIES, NEC
Previous: WASHINGTON TRUST BANCORP INC, 10-Q, 2000-05-15
Next: ADVANCED TOBACCO PRODUCTS INC, 10-Q, 2000-05-15



                     FORM 12b-25 NOTIFICATION OF LATE FILING

                                                              SEC FILE NUMBER
                                                              0-13265
                                                              CUSIP NUMBER
                                                              902633 10 6
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 (Check One):   Form 10-K       Form 20-F       Form 11-K
(X) Form 10-Q   Form N-SAR
For Period Ended: March 31, 2000
                  --------------
[  ] Transition Report on Form 10-K
[  ] Transition Report on Form 20-F
[  ] Transition Report on Form 11-K
[  ] Transition Report on Form 10-Q
[  ] Transition Report on Form N-SAR
For the Transition Period Ended: __________________________
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commissions has
verified any information contained herein.

If the notification  relates to a portion of the filing checked above,  identify
the item(s) to which the notification relates:


PART 1--REGISTRANT INFORMATION (Official Text)
UCI Medical Affiliates, Inc.
Full Name of Registrant:

Former Name if Applicable

1901 Main Street, Suite 1200, Mail Code 1105
Address of Principal Executive Office (Street and Number)

Columbia, South Carolina  29201
City, State and Zip Code

PART II--RULES  12b-25(b) AND (c) (Official Text)If the subject report could not
be filed without  unreasonable effort or expense and the registrant seeks relief
pursuant to Rule  12b-25(b),  the following  should be completed.  (Check box if
appropriate)
     ( X ) (a) The reasons  described in  reasonable  detail in Part III of this
form could not be eliminated without unreasonable effort or expense;


<PAGE>


     ( X ) (b) The subject annual report,  semi-annual report, transition report
on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof,  will be filed on
or before the fifteenth  calendar day following the  prescribed due date; or the
subject  quarterly report of transition  report on Form 10-Q, or portion thereof
will be filed on or before the fifth  calendar day following the  prescribed due
date; and

     ( ) (c) The  accountant's  statement  or  other  exhibit  required  by Rule
12b-25(c) has been attached if applicable.

PART III--NARRATIVE  (Official Text)
     State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q,
N-SAR, or the transition  report or portion  thereof,  could not be filed within
the prescribed time period. (Attach Extra Sheets if Needed)

         The  filing of Form 10-Q for the  period  ended  March 31,  2000 by UCI
         Medical  Affiliates,  Inc.,  is  delayed  as the  result of  unforeseen
         accounting  complexities  being  evaluated  in regard to the  Company's
         decision to close several of its operating sites.

         The delay in this filing of Form 10-Q could not be  eliminated  without
         unreasonable effort or expense.

PART IV--OTHER INFORMATION (Official Text)
     (1) Name and  telephone  number  of  person  to  contact  in regard to this
notification

      Jerry F. Wells, Jr., CPA, EVP of Finance and CFO          (803) 252-3661
                   (Name)                               (Area Code)   (Telephone
                                                                      Number)

(2) Have all other  periodic  reports  required under Section 13 or 15(d) of the
Securities  Exchange Act of 1934 or Section 30 of the Investment  Company Act of
1940  during  the  preceding  12  months  or for such  shorter  period  that the
registrant  was  required to file such  report(s)  been filed?  If answer is no,
identify report(s). ( X ) Yes ( )No

     (3) Is it anticipated that any significant  change in results of operations
from the corresponding  period for the last fiscal year will be reflected by the
earnings  statement to be included in the subject report or portion thereof?
( )Yes ( X ) No

If so, explain the anticipated change, both narratively and quantitatively, and,
if  appropriate,  state the  reasons  why a  reasonable  estimate of the results
cannot be made.

         UCI Medical Affiliates, Inc.
 (Name of Registrant as Specified in Charter)

     has caused this  notification to be signed on its behalf by the undersigned
hereunto duly authorized.

Date:    May 15, 2000                 By:   /s/ Jerry F. Wells, Jr., CPA
                                            Jerry F. Wells, Jr., CPA
                                            Executive Vice President of Finance
                                            and Chief Financial Officer




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission